ClinicalTrials.gg
Not yet recruitingNCT07706894Updated Jul 16, 2026

Diagnostic Accuracy of Educated Large Language Models in Endodontic Diagnosis and Case Difficulty Assessment

An observational study in Pulpal and Periapical Diseases, sponsored by Cairo University. Not yet recruiting. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2026-07-16.

Sponsored by Cairo University · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
349
Ages
16 Years and older
Sex
All
01

Study summary

This diagnostic test accuracy (DTA) study aims to evaluate the diagnostic performance of educated large language models (Educated ChatGPT (GPT-5.5 Pro), Educated Gemini 3.1 Pro, and Educated Claude Opus 4.7) in endodontic practice. Their ability to establish pulpal and periapical diagnoses and assess endodontic case difficulty will be compared with the reference standard established by a panel of endodontic experts. Clinical and radiographic information from patients presenting for primary endodontic treatment or nonsurgical endodontic retreatment will be provided to both the AI models and the expert panel. The primary outcomes are the sensitivity, specificity, and the overall accuracy of the educated LLMs, with the objective of determining their potential role as reliable decision-support tools in endodontic diagnosis and treatment planning.

02

Conditions studied

  • Pulpal and Periapical Diseases

Browse trials for

03

In context

Periapical Diseases

46 studies on the registry are indexed under Periapical Diseases; 10 are open to participants now.

Browse Periapical Diseases studies →

Lead sponsor

Cairo University is the lead sponsor of 4,967 studies on the registry; 1,474 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Eligible patients seeking primary endodontic treatment or retreatment

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age above 16 years old.
  2. Requiring primary endodontic treatment or retreatment.
  3. Availability of complete clinical examination records.
  4. Availability of diagnostic radiographs.
  5. Restorable teeth.
  6. Patient's acceptance to participate in the study.

Exclusion criteria

Exclusion Criteria:

  1. Incomplete records
  2. Pregnant women.
  3. No restorability: Hopeless tooth.
  4. Traumatic dental injuries
  5. Periapical radiographic images of sub-optimal quality or artifacts/high scatter interfering with proper assessment.
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
349 participants (estimated)
Patient registry
No

Interventions

  • Diagnostic testChatGPT, Gemini, Calude

    Three educated large language models (LLMs) will be evaluated in this study: Educated ChatGPT (GPT-5.5 Pro, OpenAI), Educated Gemini 3.1 Pro (Google), and Educated Claude Opus 4.7 (Anthropic).

06

What researchers measure

Primary outcomes

  1. Endodontic diagnosis according to AAE

    Pulpal and periapical diagnosis

    Time frame: baseline

Secondary outcomes

  1. Difficulty assessment according to AAE

    Time frame: baseline

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jul 2026; primary completion for Dec 2026, 5 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 5, 2026
First posted
Jul 16, 2026
StartEst.
Jul 2026
Primary completionEst.
Dec 2026
CompletionEst.
Jun 2027
Last update
Jul 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07706894
Lead sponsor
Cairo University
Responsible party
Radwa Mohamed Saleh Elaguizy (Assistant lecturer, Cairo University) — Principal investigator
First posted
Jul 16, 2026
Start date
Jul 2026 (estimated)
Primary completion
Dec 2026 (estimated)
Completion
Jun 2027 (estimated)
Last update
Jul 16, 2026
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion